Skip to main content
Biomind Labs logo

Biomind Labs — Investor Relations & Filings

Ticker · BMND LEI · 254900YBPPG0XSZOE887 NEO Professional, scientific and technical activities
Open in API
Filings indexed 196 across all filing types
Latest filing 2026-04-20 Regulatory Filings
Country CA Canada
Listing NEO BMND

About Biomind Labs

https://www.biomindlabs.com/

Biomind Labs is a biotechnology research and development company focused on creating novel pharmaceutical drugs for patients suffering from neurological and psychiatric disorders. The company employs an R&D acceleration platform to develop next-generation formulations, including those based on key endogenous substances. A core technological focus is the integration of nanotech delivery systems to target the underlying drivers of disease.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2026-04-20 English
News release - English.pdf
Regulatory Filings
2026-04-20 English
Annual information form - English.pdf
Regulatory Filings
2026-04-01 English
Annual information form - English.pdf
Annual Report Classification · 1% confidence The document is explicitly titled 'ANNUAL INFORMATION FORM' (AIF) for the year ended December 31, 2025. In Canadian securities regulation, an Annual Information Form is a disclosure document that provides material information about a company and its business, including risk factors, corporate structure, and governance. While it is not a financial statement-heavy '10-K' (which is a US-specific term), it serves the equivalent function of a comprehensive annual disclosure document in the Canadian market. Given the provided filing categories, '10-K' is the closest functional equivalent for a comprehensive annual disclosure report, or it could be classified under 'RNS' as a regulatory filing. However, since it is a primary annual disclosure document, '10-K' is the standard classification for such annual reports in this taxonomy. FY 2025
2026-04-01 English
Annual information form - English.pdf
Annual Report Classification · 1% confidence The document is explicitly titled 'ANNUAL INFORMATION FORM' (AIF) for Biomind Labs Inc. for the year ended December 31, 2025. An Annual Information Form is a standard Canadian regulatory filing that provides material information about a company, its business, and its risks, similar in function to a 10-K in the United States. Since the provided categories include '10-K' as the classification for official yearly reports covering company activity, and the AIF is the Canadian equivalent of the 10-K, it is classified as 10-K. FY 2025
2026-04-01 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is Form 13-502F1 filed with the Ontario Securities Commission certifying and calculating the participation fee for a reporting issuer. It is a regulatory submission rather than an annual report, earnings release, or other specified corporate announcement. It does not fit any more specific category, so it falls under the general “Regulatory Filings” fallback category.
2026-04-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.